Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission

X. P. Wang, N. Oyaizu, Savita G Pahwa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Approximately 70% of human immunodeficiency virus (HIV)-1-infected pregnant women do not transmit HIV to their offsprings. The identification of factors involved in maternal-child transmission of HIV is important for the design and implementation of therapeutic and prevention strategies. Recently we have developed a modified peripheral mononuclear cell (PBMC) culture system for in vitro antibody production (IVAP) by which we can distinguish serum-derived cytophilic anti-HIV-1 antibody from de novo synthesized antibody. In this study, we analyzed the presence of antibodies directed to HIV-1 gp160, gp120, gp41, and V3 loop synthetic peptides (C51, C53, and C57 from MN and IIIB strains) utilizing the grid-blot method in PBMC cultures of 52 mother-child pairs. Among the mothers (39 nontransmitters and 13 transmitters), presence of serum-derived cytophilic antibodies or de novo synthesized HIV V3 loop peptide-specific antibodies did not correlate with vertical transmission. However, PBMC-associated, cytophilic antibodies of maternal origin reactive with C51, C53, and C57 from MN and IIIB strains were identified in cultures of uninfected infants, but not in infected infants. These observations suggest that cytophilic antibodies of maternal origin directed to HIV-1 V3 loop peptides which are bound to infant cells might play a role in preventing vertical transmission.

Original languageEnglish
Pages (from-to)384-389
Number of pages6
JournalPediatric Research
Volume38
Issue number3
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

HIV-1
Mothers
HIV
Peptides
Antibodies
Serum
Antibody Formation
Pregnant Women
Cell Culture Techniques

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission. / Wang, X. P.; Oyaizu, N.; Pahwa, Savita G.

In: Pediatric Research, Vol. 38, No. 3, 01.01.1995, p. 384-389.

Research output: Contribution to journalArticle

@article{9facc7a70ae5416d99cb58c8938a58b6,
title = "Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission",
abstract = "Approximately 70{\%} of human immunodeficiency virus (HIV)-1-infected pregnant women do not transmit HIV to their offsprings. The identification of factors involved in maternal-child transmission of HIV is important for the design and implementation of therapeutic and prevention strategies. Recently we have developed a modified peripheral mononuclear cell (PBMC) culture system for in vitro antibody production (IVAP) by which we can distinguish serum-derived cytophilic anti-HIV-1 antibody from de novo synthesized antibody. In this study, we analyzed the presence of antibodies directed to HIV-1 gp160, gp120, gp41, and V3 loop synthetic peptides (C51, C53, and C57 from MN and IIIB strains) utilizing the grid-blot method in PBMC cultures of 52 mother-child pairs. Among the mothers (39 nontransmitters and 13 transmitters), presence of serum-derived cytophilic antibodies or de novo synthesized HIV V3 loop peptide-specific antibodies did not correlate with vertical transmission. However, PBMC-associated, cytophilic antibodies of maternal origin reactive with C51, C53, and C57 from MN and IIIB strains were identified in cultures of uninfected infants, but not in infected infants. These observations suggest that cytophilic antibodies of maternal origin directed to HIV-1 V3 loop peptides which are bound to infant cells might play a role in preventing vertical transmission.",
author = "Wang, {X. P.} and N. Oyaizu and Pahwa, {Savita G}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "384--389",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission

AU - Wang, X. P.

AU - Oyaizu, N.

AU - Pahwa, Savita G

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Approximately 70% of human immunodeficiency virus (HIV)-1-infected pregnant women do not transmit HIV to their offsprings. The identification of factors involved in maternal-child transmission of HIV is important for the design and implementation of therapeutic and prevention strategies. Recently we have developed a modified peripheral mononuclear cell (PBMC) culture system for in vitro antibody production (IVAP) by which we can distinguish serum-derived cytophilic anti-HIV-1 antibody from de novo synthesized antibody. In this study, we analyzed the presence of antibodies directed to HIV-1 gp160, gp120, gp41, and V3 loop synthetic peptides (C51, C53, and C57 from MN and IIIB strains) utilizing the grid-blot method in PBMC cultures of 52 mother-child pairs. Among the mothers (39 nontransmitters and 13 transmitters), presence of serum-derived cytophilic antibodies or de novo synthesized HIV V3 loop peptide-specific antibodies did not correlate with vertical transmission. However, PBMC-associated, cytophilic antibodies of maternal origin reactive with C51, C53, and C57 from MN and IIIB strains were identified in cultures of uninfected infants, but not in infected infants. These observations suggest that cytophilic antibodies of maternal origin directed to HIV-1 V3 loop peptides which are bound to infant cells might play a role in preventing vertical transmission.

AB - Approximately 70% of human immunodeficiency virus (HIV)-1-infected pregnant women do not transmit HIV to their offsprings. The identification of factors involved in maternal-child transmission of HIV is important for the design and implementation of therapeutic and prevention strategies. Recently we have developed a modified peripheral mononuclear cell (PBMC) culture system for in vitro antibody production (IVAP) by which we can distinguish serum-derived cytophilic anti-HIV-1 antibody from de novo synthesized antibody. In this study, we analyzed the presence of antibodies directed to HIV-1 gp160, gp120, gp41, and V3 loop synthetic peptides (C51, C53, and C57 from MN and IIIB strains) utilizing the grid-blot method in PBMC cultures of 52 mother-child pairs. Among the mothers (39 nontransmitters and 13 transmitters), presence of serum-derived cytophilic antibodies or de novo synthesized HIV V3 loop peptide-specific antibodies did not correlate with vertical transmission. However, PBMC-associated, cytophilic antibodies of maternal origin reactive with C51, C53, and C57 from MN and IIIB strains were identified in cultures of uninfected infants, but not in infected infants. These observations suggest that cytophilic antibodies of maternal origin directed to HIV-1 V3 loop peptides which are bound to infant cells might play a role in preventing vertical transmission.

UR - http://www.scopus.com/inward/record.url?scp=0029093604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029093604&partnerID=8YFLogxK

M3 - Article

C2 - 7494664

AN - SCOPUS:0029093604

VL - 38

SP - 384

EP - 389

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 3

ER -